SANA ALI: Open Payments
NPI 1396238408 · BOWLING GREEN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,033 in 49 payments from 16 companies in 2025. Trend: 2023 $984 · 2024 $1,249 · 2025 $1,033
Food & beverage: $1,033
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 10 | $223 |
| Alkermes, Inc. | 6 | $103 |
| Janssen Pharmaceuticals, Inc | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $83 |
| Lundbeck LLC | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
| Tris Pharma Inc | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
Products named: Azstarys, TRINTELLIX, REXULTI, LYBALVI, CAPLYTA, INVEGA SUSTENNA, COBENFY, INGREZZA.
Industry payments across KY — which companies pay providers there.
